Hain Celestial Group Inc Dossier - Source-backed chat

Hain Celestial Group Inc

HAINNASDAQ

SectorConsumer Staples

IndustryPackaged Foods & Meats

Beta (adjusted)0.81

Intrinsic Value

No headline value published yetWe haven't published a headline intrinsic value for this company yet. Our data-reliability standards weren't met. Method estimates are shown for reference.

Market Price $0.51Price as of 1 Oct 2026

Data confidence Sign in to view data confidence

Market Cap $46.4M

Enterprise Value $546.7M

Shares Outstanding 90.7M diluted

Moat Rating None

Next Earnings Date6 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Hain Celestial is in the midst of a multi-year operational turnaround under its 'Hain Reimagined' strategy. The company has successfully executed on critical balance sheet stabilization, notably reducing total debt by $155 million in Q3 Fiscal 2026 following the divestiture of its North American snacks business. Sequential improvements in adjusted gross margin and adjusted EBITDA margin demonstrate enhanced financial discipline. However, top-line headwinds persist, with organic net sales declining 8% in the most recent quarter, driven by volume losses in meal prep, baby & kids, and international segments. Given the lack of near-term revenue visibility and the ongoing restructuring, a Hold recommendation is warranted until top-line stabilization is achieved.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets4 analysts · as of 18 Aug 2026

Low · most bearish analyst$0.50

Mean target$1.33

High · most bullish analyst$3.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$0.5015%

The bear case reflects persistent volume declines and market share losses to private label and larger consumer packaged goods competitors. If cost inflation outpaces productivity savings and pricing actions, gross margins will contract. Inability to stabilize the top line could lead to further goodwill and asset impairment charges, putting pressure on covenant compliance and restricting financial flexibility.

Base CaseCentral scenario

$0.8360%

The base case assumes sequential stabilization of margins and a gradual moderation of organic sales declines. Restructuring efforts, including the 30% SKU reduction in North America and the divestiture of lower-margin businesses, will keep adjusted gross margins around 21% and adjusted EBITDA margins in the high single digits. Debt reduction will continue incrementally, keeping the leverage ratio stable as the company works through its turnaround.

Bull CaseUpside scenario

$1.5025%

The bull case is predicated on a faster-than-expected recovery in organic sales, driven by core brands in tea, yogurt, and personal care. Continued productivity savings and pricing power could expand adjusted gross margins beyond historical averages. Successful deleveraging below a 3.5x net secured leverage ratio would reduce interest expenses and improve net income margins, driving a re-rating of the stock toward its historical multiples.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Significant debt reduction of $155 million in Q3 Fiscal 2026, materially improving the balance sheet and liquidity profile.
Sequential improvements in adjusted gross margin (up 150 bps sequentially to 21%) and adjusted EBITDA margin (up to 7.8%).
Portfolio simplification through the completed divestiture of the North American snacks business, allowing management to focus on higher-margin core categories.

Key Investment Risks

Persistent top-line pressure, with organic net sales declining 8% year-over-year in Q3 Fiscal 2026.
Elevated leverage with a net secured leverage ratio of 4.3x under the credit agreement.
Execution risk associated with the ongoing turnaround strategy and SKU rationalization program.

Thesis Invalidation Triggers

Net secured leverage ratio exceeding covenant limits under the credit agreement.
Failure to stabilize organic net sales growth, resulting in double-digit declines in consecutive quarters.
Further material goodwill or long-lived asset impairment charges indicating deterioration of brand equity.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.